Massivemarkets

ENOV

Enovis Corporation

NYSE · usd

$27.68+0.04 (+0.14%)
As of 7:30:07 PM EST on Nov 13, 2026 · 15-minute delayed

Enovis Corporation (ENOV) trades at $27.68 (+0.14%) as of 7:30:07 PM EST on Nov 13, 2026, +43.05% over the past month. Market cap is $1.59B, with 7.3 days to cover in short interest.

Stock performance

How Enovis Corporation (ENOV) stock has performed from one day to one year, with its 52-week range.

-1.51%
-$0.43 over 1D
$27.72$28.08$28.45$28.819:30 AM11:10 AM12:50 PM2:25 PM8:00 PM$27.68
1D
+0.14%
1W
+1.91%
1M
+43.05%
YTD
+3.90%
1Y
-7.70%
52-wk range
$16.70 – $31.67

Key statistics

Today's trading snapshot for ENOV: day range, open, previous close, volume and market cap.

Day range
$27.63 – $28.89
Open
$28.65
Prev close
$27.64
Volume
1.21M
Market cap
$1.59B
Shares out
57.69M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Enovis Corporation: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
0.69
P/B
1.07
P/FCF
22.92
ROE
-35.3%
ROA
-14.1%
Debt/Equity
0.84
Div yield
0.00%

As of Nov 12, 2026

8-K filings

Material corporate events Enovis Corporation has disclosed to the SEC on Form 8-K.

  • On November 5, 2026, the Company issued a press release reporting financial results for the third quarter ended October 2, 2026.

  • Acquisition agreementSep 1, 2026

    On August 31, 2026, Enovis Corporation (the "Company") entered into a binding offer to acquire eCential Robotics SAS ("eCential")... Under the terms of the agreement, the Company will acquire eCential based on an enterprise value of approximately €155,000,000, subject to certain adjustments, which corresponds to up-front consideration of approximately €176,000,000 in cash to be paid to eCential shareholders upon the closing of the acquisition, and, to the extent that certain milestones are achieved, up to an additional €35,000,000 in cash.

  • Executive compensation changeMay 19, 2026

    The 2020 Plan Amendment (i) authorizes an additional 3,650,000 shares of the Company's common stock, par value $0.001 per share, for issuance under the 2020 Omnibus Incentive Plan and (ii) increases the maximum aggregate dollar value of equity-based awards and cash compensation that may be granted to any Outside Director from $350,000 to $750,000.

  • Executive compensation changeDec 15, 2025

    During the Transition Period, Ms. Lang will continue to receive her current base salary for a period of six months, after which her base salary will be reduced by up to 50% for the remainder of the Transition Period. Ms. Lang will remain eligible to participate in the Company benefit plans in which she currently participates, including the Company's annual incentive plan.

  • Credit facilityDec 10, 2025

    The Amended Credit Agreement provides for a revolving credit facility of up to $1.1 billion (the "Revolving Facility" and the loans thereunder, the "Revolving Loans") and a term loan facility of $700.0 million (the "Term Loan Facility" and the loans thereunder, the "Term Loans"). The Third Amendment extended the maturity date for all outstanding Revolving Loans and Term Loans to December 8, 2030.

ENOV short interest

How heavily ENOV is shorted: shares short, days to cover and average daily volume.

Days to cover
7.3
Short interest
10.56M
Avg volume
1.45M

As of · reported to FINRA twice monthly.

ENOV news

The latest news and headlines about Enovis Corporation (ENOV).

Frequently asked questions

What is the Enovis Corporation (ENOV) stock price today?

Enovis Corporation (ENOV) is trading at $27.68 (+0.14% on the day) as of 7:30:07 PM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Enovis Corporation?

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy.

What is the short interest in ENOV?

As of Oct 30, 2026, ENOV has 10.56M shares short and 7.3 days to cover.

What exchange is ENOV listed on?

Enovis Corporation (ENOV) trades on NYSE in USD, in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry.

Build with AI

Build an analysis of ENOV with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ENOV analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.